Denosumab – a new medication in the treatment of postmenopausal osteoporosis
Osteoporosis is a chronic, systemic skeletal disorder characterised by decreased bone density. It leads to an increased risk of bone fractures – one of the major causes of disability in modern societies. Bisphosphonates are the most commonly used medications in the treatment of postmenopausal oste...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2017-10-01
|
| Series: | Menopause Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Denosumab-a-new-medication-in-the-treatment-of-postmenopausal-osteoporosis,4,30778,1,1.html |